The immninent dawn of SPRMs in obstetrics and gynecology

Nathalie Chabbert-Buffet, Nathalie Chabbert‐Buffet, Axelle Pintiaux, Philippe Bouchard
Molecular and cellular endocrinology · 2012 · vol. 358(2) , pp. 232–243 · doi:10.1016/j.mce.2012.02.021 · PMID:22415029 · W2000777228
review OA: closed CC0 ⤵ 14 in-corpus citations
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex View on PubMed
⚙ AI-generated summary by claude@2026-06, 2026-06-09 ⓘ

This review discusses the potential applications of selective progesterone receptor modulators (SPRMs) in obstetrics and gynecology, highlighting their mechanisms and therapeutic promise.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

MeSH descriptors

Gynecology Hormone Antagonists Obstetrics Contraception Female Hormone Antagonists Hormone Antagonists Hormone Antagonists Humans Mifepristone Mifepristone Mifepristone Mifepristone Receptors, Progesterone Receptors, Progesterone Receptors, Progesterone

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (100)

Cited by (14)

Source provenance

europepmc
last seen: 2026-06-24T06:10:11.469335+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:16:17.081435+00:00
License: CC0 · commercial use OK